The Study of the efficacy, safety and tolerability of low molecular weight heparin vs. unfractionated heparin in patients with embolic stroke due to atrial fibrillation -

Trial Profile

The Study of the efficacy, safety and tolerability of low molecular weight heparin vs. unfractionated heparin in patients with embolic stroke due to atrial fibrillation -

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Enoxaparin sodium (Primary) ; Heparin; Warfarin
  • Indications Stroke; Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Mar 2014 Recruitment is expected to complete on 01 Feb 2016, as per Iranian Registry of Clinical Trials record.
    • 22 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top